ReShape Duo Delivers Weight Loss In Sham-Controlled Pivotal Trial
This article was originally published in The Gray Sheet
Executive Summary
The REDUCE US pivotal trial of ReShape Medical’s Duo dual intragastric balloon weight-loss therapy is the first prospective randomized pivotal trial of a device to treat obesity to meet its primary efficacy endpoints, according to the San Clemente, California, company.